Aster DM Healthcare jumps on starting COVID-19 test in Bengaluru

Aster DM Healthcare jumped 5.05% to Rs 99.80 after the company said its diagnostics arm has started providing RT-PCR confirmatorytest service forCovid-19 in Bengaluru.

Aster Clinical Lab LLP (Aster Labs), the diagnostics arm of Aster DM Healthcare, the largest integrated healthcare network in GCC and emerging healthcare player in India has started providing RT-PCR confirmatory test service for Covid-19 in Bengaluru.

Aster Labs has set up its pathology reference laboratory at Queens Road, Bengaluru, which is fully equipped to serve routine and specialized investigation. It has approval from The Indian Council for Medical Research (ICMR) to start full-fledged testing of COVID-19 RT-PCR confirmatory test, which remains a Gold Standards for Covid-19 testing.

The announcement comes at a time when Bengaluru is preparing to emerge from the lockdown and testing becomes essential to control the spread of Covid-19 infection through fast identification, quarantine, isolation and treatment. The announcement was made after market hours yesterday, 6 May 2020.

RT-PCR (reverse transcription polymerase chain reaction) is a laboratory technique used for detecting the presence of specific genetic material from any pathogen, including a virus.

On a consolidated basis, the company's net profit rose 38.6% to Rs 139.12 crore on an 8% increase in net sales to Rs 2321.66 crore in Q3 December 2019 over Q3 December 2018.

Aster DM Healthcare operates in various segments of the healthcare industry, which include hospitals, clinics and retail pharmacies, and provides healthcare services to patients across economic segments in various gulf corporation council (GCC) states through its various brands, such as Aster, Medcare and Access.

Powered by Capital Market - Live News